AVITA Medical (RCEL) Gross Profit (2018 - 2025)

AVITA Medical has reported Gross Profit for 8 years, with the latest figure at $14.3 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit fell 11.26% year-over-year to $14.3 million; the trailing twelve-month figure through Dec 2025 stood at $58.8 million (up 6.63% YoY), and the FY2025 full-year result was $58.8 million, up 6.63% from the prior year.
• Gross Profit for Q4 2025 stood at $14.3 million, up from $13.9 million in the prior quarter.
• The five-year high for Gross Profit was $16.4 million in Q3 2024, with the low at $5.8 million in Q1 2022.
• Historically, Gross Profit has averaged $11.0 million across 5 years, with a median of $10.6 million in 2023.
• Annual changes were most pronounced in 2021 — Gross Profit soared 174.76% — and 2025, when it declined 15.17%.
• AVITA Medical's Gross Profit stood at $5.9 million in 2021, then jumped by 36.68% to $8.1 million in 2022, then surged by 52.92% to $12.4 million in 2023, then jumped by 30.06% to $16.1 million in 2024, then fell by 11.26% to $14.3 million in 2025.
• The last three Gross Profit figures came in at $14.3 million (Q4 2025), $13.9 million (Q3 2025), and $14.9 million (Q2 2025), per Business Quant data.